首页> 外国专利> Simple procedure for obtaining advanced intermediates in the preparation of lipophilic analogues of the gamma aminobutyric acid (GABA) from adducts of Morita Baylis - Hillman

Simple procedure for obtaining advanced intermediates in the preparation of lipophilic analogues of the gamma aminobutyric acid (GABA) from adducts of Morita Baylis - Hillman

机译:从森田贝利斯的加合物制备γ-氨基丁酸(GABA)亲脂性类似物中获得高级中间体的简单程序

摘要

The present invention provides a process for obtaining the form racêmica new intermediaries advanced gamma amino butyric acid (GABA), referred to as the gamma nitrohidroxiesteres alpha alkyl substituted.By using the reaction of Morita Baylis - Hillman (MBH).The advanced intermediates proposed here are substrates for the production of synthetic lipophilic analogues of GABA.We are currently used for the treatment of various types of neurodegenerative diseases that are associated with ageing, Alzheimer's disease, Parkinson's disease, Huntington, schizophreniaAlso, epilepsy and anxiety, among others.The compounds known as gamma nitrohidroxiesteres alpha alkyl substituted are obtained in two steps with good yields.Being the key stage the reaction of Morita Baylis - Hillman using substrates with chains greases consist of four to twenty two carbons (C4 - C22), linear, branched, saturated,Monounsaturated and polyunsaturated fat. The key stage of the process used a catalyst of low cost and environmentally friendly commercial reagents and low cost.In addition, from the gamma nitrohidroxiésteres alpha alkyl substituted was the hydroxy gamma lactams alpha alkyl substituted lipophilic analogues of GABA.Allowing a new solution to the improvement of the problem for the transposition of the blood-brain barrier (BH), a highly lipophilic, and represent a viable alternative.By eliminating the effect of high doses of the compounds used commercially, which cause severe side effects.Representing a broad spectrum of pharmacological and potential technological applications.
机译:本发明提供了一种以racêmica形式获得新中间体高级γ-氨基丁酸(GABA)的方法,该新中间体被称为γ-亚硝基羟基甲酸酯α-烷基取代。通过使用森田贝利斯-希尔曼(MBH)的反应。是生产合成的GABA亲脂性类似物的底物。我们目前用于治疗各种与衰老,阿尔茨海默氏病,帕金森氏病,亨廷顿病,精神分裂症有关的神经退行性疾病,此外还患有癫痫和焦虑症等化合物。分两步获得具有良好收率的被称为γ-亚硝基羟基甲酸酯的α-烷基。作为关键阶段,Morita Baylis-Hillman使用带有链状润滑脂的底物进行反应,由四到二十二个碳原子(C4-C22)组成,为直链,支链,饱和碳原子,单不饱和和多不饱和脂肪。该工艺的关键阶段使用了低成本,环保的商业试剂和低成本的催化剂。此外,γ-硝基hidroxiésteres的α烷基取代是GABA的羟基γ内酰胺α烷基取代的亲脂性类似物。改善了高度亲脂性血脑屏障(BH)的转位问题,是一种可行的选择。通过消除高剂量商业使用的化合物的作用,这会导致严重的副作用。药理学和潜在技术应用。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号